Showing results (761-770 of 1,544) with videos related to

Sort By:
Pageof 155
Toxicologic Pathology|May 12, 2011
Spontaneous thymoma in a juvenile cynomolgus macaque (Macaca fascicularis)J A Schwartz, J A Solomon, K Henkelman, et al.
Annals of Internal Medicine|March 15, 1990
Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysisJ N Buxbaum, J V Chuba, G C Hellman, et al.
Clinical and Experimental Rheumatology|June 7, 2011
Burden of depressive symptoms in South African public healthcare patients with established rheumatoid arthritis: a case-control studyA Solomon, B F Christian, A J Woodiwiss, et al.
Neurosurgery|July 1, 1995
Serum elastase and alpha-1-antitrypsin levels in patients with ruptured and unruptured cerebral aneurysmsC J Baker, A Fiore, E S Connolly, et al.
Brain Research|September 9, 2004
Astrocytic proliferation in the piriform cortex of amygdala-kindled subjects: a quantitative study in partial versus fully kindled brainsMani Vessal, Chandrasagar B Dugani, Dianand A Solomon, et al.
The Journal of Biological Chemistry|June 23, 1995
Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and VL fragmentS Paul, L Li, R Kalaga, et al.
Bipolar Disorders|November 27, 2008
Preventing recurrence of bipolar I mood episodes and hospitalizations: family psychotherapy plus pharmacotherapy versus pharmacotherapy aloneDavid A Solomon, Gabor I Keitner, Christine E Ryan, et al.
Neurosurgical Focus|July 6, 2006
J. Lawrence Pool, M.D.: a pioneer in vascular neurosurgeryBrad E Zacharia, J Mocco, Ricardo J Komotar, et al.
BMJ (Clinical Research Ed.)|November 2, 1991
beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combinationS A Solomon, L E Ramsay, W W Yeo, et al.
Cutis|November 23, 2016
Patient-reported outcomes of azelaic acid foam 15% for patients with papulopustular rosacea: secondary efficacy results from a randomized, controlled, double-blind, phase 3 trialStephen Tyring, James A Solomon, Gerald Staedtler, et al.
Pageof 155